1. Balasanyants G.S., Sukhanov D.S. Pobochnye deystviya protivotuberkuleznykh preparatov i metody ikh ustraneniya. [Side effects to anti-tuberculosis drugs and methods of their management]. 3rd ed., revised, St. Petersburg, 2014, 64 p.
2. Vavilova А.А., Kochergin G.А. On the issue of the vestibular toxicity effect of aminoglycosides. RMJ, 2017, no. 6, pp. 435-438. (In Russ.)
3. Golubchikov P.N., Kruk E.А., Mishustin S.P., Petrenko T.I., Kudlay D.А. Experience of treating extensive drug resistant tuberculosis patients including continuous use of bedaquiline, in Tomsk Region: immediate and postponed results. Tuberculosis and Lung Diseases, 2019, vol. 97, no. 8, pp. 38-45. (In Russ.)
4. Ivanova D.А. Nezhelatelnye reaktsii pri lechenii vpervye vyyavlennykh bolnykh tuberkulezom organov dykhaniya: profilaktika, rannyaya diagnostika i kupirovanie. Avtoref. diss. dokt. med. nauk. [Adverse reactions to treatment of new respiratory tuberculosis cases: prevention, early diagnostics and management. Synopsis of Doct. Diss.]. Moscow, 2018. 44 p.
5. Ivanova D.А., Borisov S.E. Discontinue or wait ?: indications for cancellation of anti-tuberculosis drugs due to adverse reactions. Tuberculosis and Lung Diseases, 2018, vol. 96, no. 2, pp. 47-54. (In Russ.)